Sightsavers Logo
Research centre
  • Home
  • About us
  • Research approach
  • Research studies and publications
  • Evidence gap maps
Join in:
  • Join in: Facebook
  • Join in: Twitter
  • Join in: Instagram
  • Join in: LinkedIn
  • Join in: YouTube
  • Global
  • Close search bar
    Donate
    • Home
    • About us
    • Research approach
    • Research studies and publications
    • Evidence gap maps

    The protective effect of ophthalmic viscoelastic devices on endothelial cell loss during cataract surgery: a meta-analysis using mixed treatment comparisons

    Methodological quality of the review: Low confidence

    Author: Van den Bruel A, Gailly J, Devriese S, Welton NJ, Shortt AJ, Vrijens F.

    Region: Details not provided

    Sector: Ophthalmic viscoelastic devices, endothelial cell loss and cataract surgery.

    Sub-sector: Viscoadaptives, super viscosity cohesives, viscous cohesives, medium viscosity dispersives, very low viscosity dispersives.

    Type of cataract: Age-related cataract

    Equity focus: None specified

    Review type: Effectiveness review

    Quantitative synthesis method: Meta-analysis

    Qualitative synthesis methods: Not applicable

    Background

    Any direct trauma to the corneal endothelium results in a decrease in the number of cells of the lining. When cell density falls below 500-1000 cells/mm2, the cornea becomes ‘oedematous and assumes the clinical appearance of bullous keratopathy, a serious complication that may occur following cataract surgery in up to 0.3% of patients’.  Due to the link between surgical trauma and endothelial cell loss, surgeons use protective ophthalmic viscosurgical devices (OVDs) to minimize cell loss. To date, there is little data to support the use of one type of OVD over another in terms of minimizing endothelial cell loss following cataract surgery.

    Research objectives

    ‘To compare ophthalmic viscoelastic devices (OVDs) in protecting the cornea from endothelial cell loss during cataract surgery’.

    Main findings

    The review included 21 randomized controlled trials evaluating the effect of OVDs on endothelial cell density in patients undergoing cataract surgery.

    Direct comparison meta-analysis indicated that viscoadaptives led to a lower loss of cell density, with one study finding a lower loss of cell density of 198 (95% CI 99 to 298) cells/mm2, and three studies finding a lower cell loss of 112 (95% CI 14 to 211) cells/mm2, compared with super viscous cohesives. Compared with other OVDs, no significant differences were identified. The soft shell technique showed a statistically significant lower loss compared with viscous cohesives, of 36 (95% CI 3 to 69) cells/mm2.

    Mixed treatment comparisons indicate that viscoadaptives had an 80% chance to be the best treatment, followed by soft shell technique at 18%. Differences between each treatment option analysed were very small, with <100 cells/mm2 between various OVDs in endothelial cell density loss three months after cataract surgery.

    Overall, authors concluded that viscoadaptives were potentially superior to other OVD types, with other treatments never coming out as the best strategy. Absolute differences between the OVDs analysed in loss in endothelial cell density were <100 cells/mm2, meaning that differences may not be clinically relevant in most patients. Authors suggested that a cost-effectiveness analysis of OVD treatment options needed to be addressed in future research.

    Methodology

    The authors included randomized controlled trials evaluating the effect of OVDs on endothelial cell density in patients undergoing cataract surgery. The outcome measure for the review was loss in endothelial cell density three months after surgery.

    Authors searched MEDLINE and EMBASE from inception up until 2007. Studies were excluded if they were not written in English, French, German or Dutch. Selected studies were critically appraised using an extended version of the Jadad scale, subsequently, data were extracted in duplicate. Authors did not report if two reviewers conducted the study selection, data extraction and quality assessment of included studies.

    Authors conducted a meta-analysis of direct comparisons as well as a mixed treatment comparison (MTC) analysis, which combined all effects from direct and indirect comparisons to obtain estimates for all comparisons. A difference of more than 100 cells/mm2 was considered a clinically relevant difference.

    Applicability/external validity

    Authors did not directly discuss the applicability or external validity of the review findings.

    Geographic focus

    Authors did not provide geographical location of included studies.

    Quality assessment

    This review was attributed low confidence in the conclusions about the effects of this review as important limitations were identified. The authors, although covering relevant databases in the literature search, did not conduct a search of reference lists of included trials, did not contact experts for potentially relevant studies and restricted the search to published articles. It was not clear if this study covers an appropriate period of time as it was published in 2011 and searches were conducted from the beginning of the databases up until 2007. Additionally, authors did not report if article screening for inclusion in the review and data extraction of included studies were conducted by two reviewers independently. Nevertheless, the methods used to analyse the studies were clear and the quality and risk of bias for each individual study included in the review was reported. Meta-analysis seemed appropriate given the similarity in study design and outcomes of the included studies.

    Publication Details

    Van den Bruel A, Gailly J, Devriese S, Welton NJ, Shortt AJ, Vrijens F. The protective effect of ophthalmic viscoelastic devices on endothelial cell loss during cataract surgery: a meta-analysis using mixed treatment comparisons. The British Journal of Ophthalmology. 2011;95(1):5-10.

    Source

    Sightsavers Logo
    Research centre
    • Join in:
    • Join in: Facebook
    • Join in: X
    • Join in: Instagram
    • Join in: LinkedIn
    • Join in: YouTube

    Protecting sight, fighting disease and promoting equality for all

  • Accessibility
  • Sightsavers homepage
  • Our policies
  • Media centre
  • Contact us
  • Jobs
  • Cookies and privacy Terms and conditions Modern slavery statement Safeguarding

    © 2025 by Sightsavers, Inc., Business Address for all correspondence: One Boston Place, Suite 2600, Boston, MA 02108.

    Our website uses cookies

    To make sure you have a great experience on our site, we’d like your consent to use cookies. These will collect anonymous statistics to personalise your experience.

    Manage preferences

    You have the option to enable non-essential cookies, which will help us enhance your experience and improve our website.

    Essential cookiesAlways on

    These enable our site to work correctly, for example by storing page settings. You can disable these by changing your browser settings, but some parts of our website will not work as expected.

    Analytics cookies

    To improve our website, we’d like to collect anonymous data about how you use the site, such as which pages you read, the device you’re using, and whether your visit includes a donation. This is completely anonymous, and is never used to profile individual visitors.

    Advertising cookies

    To raise awareness about our work, we’d like to show you Sightsavers adverts as you browse the web. By accepting these cookies, our advertising partners may use anonymous information to show you our adverts on other websites you visit. If you do not enable advertising cookies, you will still see adverts on other websites, but they may be less relevant to you. For info, see the Google Ads privacy policy.